2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE
This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably de...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
08.06.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action. |
---|---|
AbstractList | This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action. |
Author | NAKAI, EIICHI NAKATO, KAZUHIRO MOCHIZUKI, SHINOBU MIYAKE, AKIRA MIURA, MASANORI YAHIRO, KIYOSHI KUBOTA, HIDEKI SUZUKI, TAKESHI |
Author_xml | – fullname: NAKATO, KAZUHIRO – fullname: MIYAKE, AKIRA – fullname: NAKAI, EIICHI – fullname: MIURA, MASANORI – fullname: MOCHIZUKI, SHINOBU – fullname: YAHIRO, KIYOSHI – fullname: KUBOTA, HIDEKI – fullname: SUZUKI, TAKESHI |
BookMark | eNrjYmDJy89L5WTQMNIx0THTDQnydPT19PPXNdQx1jEFc6M8_VwVXFyDPMMcQzzDXHkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgKGJuaWxpbmToTERSgBSZiTP |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 2,4,6-TRIAMINO-1,3,5-TRIAZIN-DERIVAT DERIVES DE 2,4,6-TRIAMINO-1,3,5-TRIAZINE |
ExternalDocumentID | EP1479397B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP1479397B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:00:17 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP1479397B13 |
Notes | Application Number: EP20030737464 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110608&DB=EPODOC&CC=EP&NR=1479397B1 |
ParticipantIDs | epo_espacenet_EP1479397B1 |
PublicationCentury | 2000 |
PublicationDate | 20110608 |
PublicationDateYYYYMMDD | 2011-06-08 |
PublicationDate_xml | – month: 06 year: 2011 text: 20110608 day: 08 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | ASTELLAS PHARMA INC |
RelatedCompanies_xml | – name: ASTELLAS PHARMA INC |
Score | 2.8045347 |
Snippet | This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110608&DB=EPODOC&locale=&CC=EP&NR=1479397B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-yEGChyxmu8kmOQSxedAITUKJoXgpmxf0UouN-PedxKZ60dvsLsw-4NvZb3ZnFuAOAaYJ3TJJplNBNMErIrgQpDLMklKDFYI20cjTkE9etOe5Pu_BsouFafOEfrbJERFROeK9bvfr9Y8Ty23fVm4esiVWvT36ie3KRefuU7lqyu7Y9uLIjRzZcVCSw5lNGw-SZYyRKO01p-gmzb6XjpuglPVvi-Ifw36Mylb1CfTK1QAOne7jtQEcTLf33Shuobc5hfuRoimcJDPk3kEYEaowRW-Lr0HoSS4SsvQpCVLvDCTfS5wJwS4Xu-ktvHg3OHYOfWT95QVIZcF4wSpa5jzXWC6yDC1pVWlslJsWN8QQhn-qufyn7QqOvt2inKjmNfTr94_yBu1qnd22K_IFHnB4Sg |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSP46sE0HrqRZdtte2iMfaVVKIRUQryQ7SvhgkRq_PtOK6AXvc3uJrOP5NvZb3ZnFuAWAaYKzTRIolFBVMELIrgQpNCNnFKdZYJW0cjDiAcv6tNMmzVgsY2FqfOEftbJERFRKeK9rPfr1Y8Ty63fVq7vkwVWvT34seXK2dbd1-M9Q3ZtyxuP3JEjOw5KcjSxaOVBMnUbidKeXiXnrU5OU7sKSln9tij-EeyPUdmyPIZGvmxDy9l-vNaGg-HmvhvFDfTWJ3DXV1SFk3iC3DuMRoQqTNHq4msYeZKLhGz6GIdT7xQk34udgGCX89305t54Nzh2Bk1k_fk5SHnGeMYKmqc8VVkqkgQtaVGorJ8aJtdFBzp_qun-03YDrSAeDuaDMHq-gMNvFyknPeMSmuX7R36FNrZMruvV-QLmZns3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2%2C4%2C6-TRIAMINO-1%2C3%2C5-TRIAZINE+DERIVATIVE&rft.inventor=NAKATO%2C+KAZUHIRO&rft.inventor=MIYAKE%2C+AKIRA&rft.inventor=NAKAI%2C+EIICHI&rft.inventor=MIURA%2C+MASANORI&rft.inventor=MOCHIZUKI%2C+SHINOBU&rft.inventor=YAHIRO%2C+KIYOSHI&rft.inventor=KUBOTA%2C+HIDEKI&rft.inventor=SUZUKI%2C+TAKESHI&rft.date=2011-06-08&rft.externalDBID=B1&rft.externalDocID=EP1479397B1 |